Collegium Pharmaceutical, Inc. COLL Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s return on invested capital?
- Collegium Pharmaceutical, Inc. (COLL) reported return on invested capital of 172.1% in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s return on invested capital changed year-over-year?
- Collegium Pharmaceutical, Inc.'s return on invested capital increased by 11.6% year-over-year, from 154.3% to 172.1%.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s return on invested capital?
- Over 2 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s return on invested capital has grown at a 29.0% compound annual growth rate (CAGR), from 75.5% to 125.6%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.